INSPIRE VETERINARY PARTNERS, INC.

INSPIRE VETERINARY PARTNERS, INC.IVPEarnings & Financial Report

Nasdaq · Health Care · Agricultural Services

Inspire Veterinary Partners, Inc. is a U.S.-based operator of companion animal veterinary clinics. It delivers full-spectrum pet healthcare services including preventive care, diagnostic testing, surgery, dental care, and emergency treatment for dogs, cats and other small pets, serving communities across multiple U.S. states.

IVP Q3 FY2025 Key Financial Metrics

Revenue

$4.3M

Gross Profit

N/A

Operating Profit

$-2.0M

Net Profit

$-2.5M

Gross Margin

N/A

Operating Margin

-45.6%

Net Margin

-58.5%

YoY Growth

6.6%

INSPIRE VETERINARY PARTNERS, INC. Q3 FY2025 Financial Summary

INSPIRE VETERINARY PARTNERS, INC. reported revenue of $4.3M (up 6.6% YoY) for Q3 FY2025, with a net profit of $-2.5M (up 27.6% YoY) (-58.5% margin).

Key Financial Metrics

Total Revenue$4.3M
Net Profit$-2.5M
Gross MarginN/A
Operating Margin-45.6%
Report PeriodQ3 FY2025

Revenue Breakdown

INSPIRE VETERINARY PARTNERS, INC. Q3 FY2025 revenue of $4.3M breaks down across 2 segments, led by Services at $3.1M (72.7% of total).

SegmentRevenue% of Total
Services$3.1M72.7%
Products$1.2M27.3%

INSPIRE VETERINARY PARTNERS, INC. Revenue by Segment — Quarterly Trend

INSPIRE VETERINARY PARTNERS, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Services and Products) has evolved quarter over quarter.

SegmentQ3 FY2025Q2 FY2025Q1 FY2025Q4 FY2024
Services$3.1M$3.2M$2.7M
Products$1.2M$1.1M

INSPIRE VETERINARY PARTNERS, INC. Annual Revenue by Year

INSPIRE VETERINARY PARTNERS, INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $16.6M).

YearAnnual Revenue
2024$16.6Mvs 2023

INSPIRE VETERINARY PARTNERS, INC. Quarterly Revenue & Net Profit History

INSPIRE VETERINARY PARTNERS, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q3 FY2025$4.3M+6.6%$-2.5M-58.5%
Q2 FY2025$4.3M-2.4%$-3.0M-70.8%
Q1 FY2025$3.6M-24.7%$-2.4M-66.4%
Q4 FY2024$3.3M$-4.0M-119.4%
Q3 FY2024$4.0M-1.7%$-3.5M-86.2%
Q2 FY2024$4.4M$-3.4M-77.1%
Q1 FY2024$4.8M$-3.4M-70.8%
Q3 FY2023$4.1M$-7.9M-191.4%

Income Statement

Q3 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$4.1M$4.8M$4.4M$4.0M$3.3M$3.6M$4.3M$4.3M
YoY GrowthN/AN/AN/A-1.7%N/A-24.7%-2.4%6.6%

Balance Sheet

Q3 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$21.3M$23.4M$21.9M$22.4M$20.2M$20.7M$20.8M$24.0M
Liabilities$18.6M$23.1M$25.0M$19.4M$18.6M$17.7M$20.4M$19.8M
Equity$2.7M$269853$-3.1M$3.0M$1.6M$3.0M$446262$4.2M

Cash Flow

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$-3.2M$149717$-6.3M$-677527$-1.4M$-898284$-1.3M